1 Temporal Changes and Regional Variation in Acceptance of HCV-viremic Livers.

2 New Insights into the Rational Use of HCV+ Organs Worldwide.

3 dyskeratosis congenita induced cirrhosis for liver transplantation-perioperative management

4 cholecysto-appendicostomy as partial internal biliary drainage in progressive familial intrahepatic cholestasis type 1: a case report and review of literature

5 Exercise training is safe and feasible in patients awaiting liver transplantation: a pilot randomized controlled trial.

6 Impact of pre-transplant infection management on the outcome of living-donor liver transplantation in Egypt

7 Pseudomonas aeruginosa bacteremia among liver transplant recipients

8 Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation

9 Methicillin-resistant Staphylococcus aureus bacteremia among liver transplant recipients: epidemiology and associated risk factors for morbidity and mortality

10 Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve

11 Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria

12 Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt

13 Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series

14 Impact of pre-transplant infection management on the outcome of living-donor liver transplantation in Egypt

15 Impact of pre-transplant infection management on the outcome of living-donor liver transplantation in Egypt

16 Dermatological Disorders following Liver Transplantation: An Update

17 Pseudomonas aeruginosa bacteremia among liver transplant recipients

18 Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation

19 Methicillin-resistant Staphylococcus aureus bacteremia among liver transplant recipients: epidemiology and associated risk factors for morbidity and mortality

20 Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve

21 Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria

22 Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt

23 Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series

24 Roles of Epstein–Barr virus viral load monitoring in the prediction of posttransplant lymphoproliferative disorder in pediatric liver transplantation

25 Challenging hepatitis C-infected liver transplant patients

26 Commentary on “FDG-PET predicted unfavorable tumor histology in living donor liver transplant recipients; a retrospective cohort study”

27 [Lipid spectrum and function of kidneys before and after liver transplantation].

28 Retraction: Novel Single Nucleotide Polymorphisms in Interleukin 6 Affect Tacrolimus Metabolism in Liver Transplant Patients.

29 Probable sirolimus-induced rupture of arterial anastomosis after liver transplantation in a patient intolerant of tacrolimus

30 Differences in CYP3A genotypes of a liver transplant recipient and the donor liver graft and adjustment of tacrolimus dose

31 Population pharmacokinetic model and Bayesian estimator for 2 tacrolimus formulations in adult liver transplant patients

32 Corrigendum to “Successful percutaneous treatment of biliary stenosis after living donor liver transplantation in a child” [Radiol Case Rep 14 (2019) 800–804](S1930043319301530)(10.1016/j.radcr.2019.03.039)

33 Percutaneous transhepatic stenting in management of post living donor liver transplantation hepatic venous stenosis

34 Liver transplantation as a rescue surgery after failure of embolization of a giant hepatic artery pseudoaneurysm.

35 Risk factors for the metabolic syndrome components of hypertension, diabetes mellitus, and dyslipidemia after living donor liver transplantation.

36 Infectious complications in pediatric liver transplantation candidates.

37 Liver transplantation for acute liver failure due to toxic agent ingestion in children.

38 Identification and Validation of the Predictive Capacity of Risk Factors and Models in Liver Transplantation Over Time

39 Portal vein variation and thrombosis in right lobe living donor liver transplantation

40 Effects of thiopental in cold ischemia in liver transplantation: An experimental study

41 Perioperative characteristics and management of liver transplantation for isolated methylmalonic acidemia-the largest experience in China.

42 Patient perspectives of weight gain following orthotopic liver transplantation: a qualitative study.

43 Hepatocellular carcinoma (HCC) patients listed in short wait regions remain advantaged for liver transplant (LT) following 2015 HCC policy change.

44 Mycophenolate pharmacokinetics and inosine monophosphate dehydrogenase activity in liver transplant recipients with an emphasis on therapeutic drug monitoring.

45 Determinants of Medication Adherence in Liver Transplant Recipients.

46 Splenectomy is not indicated in living donor liver transplantation.

47 How safe is pregnancy after liver transplantation? A large case series study at tertiary referral center in Turkey

48 The impact of the COVID-19 outbreak on Liver Transplantation programmes in Northern Italy.

49 Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation.

50 Links between donor macrosteatosis, interleukin-33 and complement after liver transplantation.

51 Biliary Reconstruction in Adult Live Donor Liver Transplantation - "The All Knots Outside Technique"

52 the potential role of liver transplantation as a treatment option in colorectal liver metastases

53 endoscopic management of biliary complications following liver transplantation after donation from cardiac death donors

54 transcriptome analysis of acute phase liver graft injury in liver transplantation

55 analysis of risk factors for recurrence and metastasis in patients with hepatocellular carcinoma after liver transplantation

56 survival benefits of interferon-based therapy in patients with recurrent hepatitis c after orthotopic liver transplantation

57 prospective study on the effect of omega-3 fish oil emulsion on inflammatory responses, immune function, and prognosis in patients with liver transplantation

58 perioperative monitoring of intracranial pressure using optic nerve sheath diameter in paediatric liver transplantation

59 anesthetic considerations in parturients with liver transplant

60 occult hepatitis b virus infection in liver transplant patients in a brazilian referral center

61 assessment and management of oral health in liver transplant candidates

62 safety and efficacy of small bowel examination by capsule endoscopy for patients before liver transplantation

63 postoperative resource utilization and survival among liver transplant recipients with model for end-stage liver disease score ≥40: a retrospective cohort study

64 serological studies of west nile virus in a liver transplant population

65 liver transplant candidate unsuitability: a review of the british columbia experience

66 the model for end-stage liver disease accurately predicts 90-day liver transplant wait-list mortality in atlantic canada

67 hemodynamic characterization of arterialized and nonarterialized liver transplants in the rat

68 propofol activation of the nrf2 pathway is associated with amelioration of acute lung injury in a rat liver transplantation model

69 the validity of central venous to arterial carbon dioxide difference to predict adequate fluid management during living donor liver transplantation. a prospective observational study

70 the natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation – a single-centre experience

71 gene silencing of 4-1bb by rna interference inhibits acute rejection in rats with liver transplantation

72 orthotropic liver transplantation for intractable neurological manifestations of wilson′s disease

73 outcomes following liver transplantation for patients with alcohol- versus nonalcohol-induced liver disease

74 recommendations of long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the american association for the study of liver diseases and the american society of transplantation

75 invasive fungal rhinosinusitis presenting as bell's palsy in a kidney and liver transplant recipient

76 salvage with a secondary infrahepatic cavocavostomy of the occluded modified piggyback anastomosis during split liver transplantation: a case report

77 pegylated-interferon alpha 2b and ribavirin for recurrent hepatitis c after liver transplantation: from a canadian experience to recommendations for therapy

78 contracepção e gravidez após transplante hepático: uma visão atual contraception and pregnancy after liver transplantation: an update overview

79 blood transfusion practices in liver transplantation

80 oral cavity metastasis of hepatocellular carcinoma following liver transplantation

81 o vivencial dos enfermeiros no programa de transplante de fígado de um hospital público la vivencia de los enfermeros en el programa de transplante de hígado de un hospital público nursing perceptions in the liver transplant program of a public hospital in brazil

82 an update on endoscopic management of post-liver transplant biliary complications

83 characteristic changes and their significance of peripheral follicular helper t cell subsets in liver transplant patient

84 the challenge of recurrent hepatitis c virus in liver transplant recipients

85 factors affecting health-related quality of life and physical activity after liver transplantation for autoimmune and nonautoimmune liver diseases: a prospective, single centre study

86 factors associated with postoperative prolonged mechanical ventilation in pediatric liver transplant recipients

87 liver transplantation in hiv-positive patients: the position of the brazilian groups transplante hepático em pacientes hiv-positivo: a posição dos grupos brasileiros

88 the impact of sirolimus on hepatitis c recurrence after liver transplantation

89 aortic balloon valvuloplasty prior to orthotopic liver transplantation: a novel approach to aortic stenosis and end-stage liver disease

90 resultado do inquérito nacional sobre condutas no acompanhamento e no tratamento da recurrência da hepatite c em portadores de vírus c submetidos a transplante de fígado national survey about management and treatment options of hepatitis c recurrence after liver transplantation

91 immune response following liver transplantation compared to kidney transplantation: usefulness of monitoring peripheral blood cd4+ adenosine triphosphate activity and cytochrome p450 3a5 genotype assay

92 the population pharmacokinetic models of tacrolimus in chinese adult liver transplantation patients

93 neuroendocrine liver metastases and orthotopic liver transplantation: the us experience

94 perioperative use of allogenic blood components in live-related donor orthotopic liver transplantation: a cross sectional study

95 intensive care of patient with two-stage liver transplantation- case report

96 bypass during liver transplantation: anachronism or revival? liver transplantation using a combined venovenous/portal venous bypass—experiences with 163 liver transplants in a newly established liver transplantation program

97 cytomegalovirus-associated immune thrombocytopenic purpura after liver transplantation

98 use of elderly donors (> 60 years) for liver transplantation

99 serum aspartate aminotransferase level and previous histopathological findings enable reduction of protocol liver biopsies after liver transplantation for hepatitis c

100 abo incompatible liver transplantation as a bridge to treat hellp syndrome

101 coma hiperosmolar associado ao transplante de fígado hyperosmolar coma associated with liver transplantation

Keyword Connections

Journals

Research Groups

Bibliographies